Ligand docking and scoring in DNA oligonucleotides. Binding of doxorubicin and modeled analogs to optimize sequence specificity

Medicinal Chemistry Research

Volumn 9, Issue 7-8, 1999, Pages 592-603

  Kellogg, Glen Eugene ^a   Scarsdale, J Neel ^a   Cashman, Derek J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ARTICLE; BASE PAIRING; BINDING AFFINITY; COMPLEX FORMATION; DNA SEQUENCE; DNA STRAND BREAKAGE; INTERCALATION COMPLEX; LIGAND BINDING; MOLECULAR MODEL; OLIGONUCLEOTIDE PROBE;

EID: 0033388758     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. 1. Weiss, R.B. Seminars in Oncol. 1992, 19(6), 670-686.
2. 2. Henderson, I.C.; Canellos, G.P. N. Engl. J. Med. 1990, 302, 78-90.
3. 3. Fornari, F.A.; Randolph, J.K.; Yalowich, J.C.; Ritke, M.K.; Gewirtz. D.A. Mol. Pharmacol. 1994, 45, 649-656.
4. 4. Momparler, R.L.; Karon, M.; Siegel, S.E.; Avila, F. Cancer Res. 1976, 36, 2891-2895.
5. 5. Tewey, K.M.; Rowe, T.C.; Yang, L.; Halligan, B.D.; Liu, L.F. Science 1984, 226, 466-468.
6. 6. Schneider, E.; Hsiang, Y.; Liu, L.F. Adv. Pharmacol. 1990, 21, 149-183.
7. 7. Sander, M.; Tsieh, T.-S. J. Biol. Chem. 1983, 258, 8421-8428.
8. 8. Bachur, N.F.; Yu, F.; Johnson, R.; Hickey, R.; Wu, Y.; Malkas, L. Mol. Pharmacol. 1992, 41, 993-998.
9. 9. George, J.W.; Ghate, S.; Matson, S.W; Besterman, J.M. J. Biol. Chem. 1992, 267, 10683-10689.
10. 10. Graves, D.E.; Krugh, T. Biochemistry 1983, 22, 3941-3947.
11. 11. Cullinane, C.; Cutts, S.M.; van Rosmalen, A; Phillips, D.R. Nucleic Acids Res. 1994, 22, 2296-2303.
12. 12. Frederick, C.A.;Williams, L.D.; Ughetto, G.; van der Marel, G.; van Boom, J.H.; Rich, A.; Wang, A.H.-J. Biochemistry 1990, 29, 2538-2549.
13. 13. Kellogg, G.E., Scarsdale, J.N.; Fornari, F.A., Jr. Nucleic Acids Res. 1998, 26, 4721-4732,
14. 14. Chaires, J.B.; Satyanarayana, S.; Suh, D.; Fokt, I;, Przewloka, T.; Priebe, W. Biochemistry 1996, 35, 2047-2053.
15. 15. Chaires, J.B. Curr. Opin. Struct. Biol. 1998, 8, 314-320.
16. 16. Chaires, J.B. Anti-Cancer Drug Design 1996, 11, 569-580.
17. 17. Wireko, F.C.; Kellogg, G.E.; Abraham, D.J. J. Med. Chem. 1991, 34, 758-767.
18. 18. Abraham, D.J.; Kellogg, G.E.; Holt, J.M.; Ackers, G.K. J. Mol. Biol. 1997, 272, 613-632.
19. 19. Kellogg, G.E.; Joshi, G.S.; Abraham, D.J. Med. Chem. Res. 1992, 1, 444-453.
20. 20. Gussio, R.; Pattabiraman, N.; Zaharevitz, D.W.; Kellogg, G.E.; Topol, I.A.; Rice, W.G.; Schaeffer, C.A.; Erickson, J.W.; Burt, S.K. J. Med. Chem. 1996, 39, 1645-1650.
21. 21. Kellogg, G.E.; Semus, S.F.; Abraham, D.J. J. Comp. Aid. Molec. Des. 1991, 5, 545-552.
22. 22. Arcamone, F.; Penco, S.; Vigevani, A. Cancer Chemother. Rpts. Part 3. 1975, 6, 123-129.
23. 23. Tsuruo, T.; Yusa, K.; Sudo, Y.; Takamori, R.; Sugimoto, Y. Cancer Res. 1989, 49, 5537-5542.
24. 24. Watanabe, M.; Komeshima, N.; Nakajima, S.; Tsuruo, T. Cancer Res. 1988, 48, 6653-6657.
25. 25. Inoue, K.; Ogawa, M.; Horikoshi, N.; Mukaiyama, T.; Itoh, Y.; Imajoh, K.; Ozeki, H.; Nagamine, D.; Shinagawa, K. Investigalional New Drugs. 1989, 7, 213-218.
26. 26. Sybyl is a product of Tripos, Inc., St. Louis, MO.
27. 27. Hansch, C.; Leo, A.J. Substituent Constants for Correlation Analysis in Chemistry and Biology, John Wiley and Sons,Inc. New York, 1979.
28. 28. Abraham, D. J. and Leo, A. J. Proteins: Struct. Funct. Genetics 1987, 2, 130-152.
29. 29. Levitt, M. J. Mol. Biol. 1983, 168, 595-620.
30. 30. Levitt, M.; Perutz, M.F. J. Mol. Biol. 1988, 207, 751-754.